Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Lexington (CDIX) Shares Outstanding (Weighted Average) (2016 - 2025)

Cardiff Lexington (CDIX) has 16 years of Shares Outstanding (Weighted Average) data on record, last reported at $19.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 92.88% year-over-year to $19.8 million; the TTM value through Sep 2025 reached $19.8 million, up 92.88%, while the annual FY2024 figure was $11.4 million, 79120.65% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $19.8 million in Q3 2025 per CDIX's latest filing, up from $17.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $208.8 million in Q3 2022 and bottomed at $5822.0 in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $57.4 million, with a median of $15.3 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 100.0% in 2022, then skyrocketed 106293.6% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $128.0 million in 2021, then tumbled by 100.0% to $5822.0 in 2022, then surged by 148.09% to $14444.0 in 2023, then skyrocketed by 79120.65% to $11.4 million in 2024, then surged by 72.65% to $19.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $19.8 million in Q3 2025, $17.0 million in Q2 2025, and $15.3 million in Q1 2025.